CATHERINE HERNANDEZ: Open Payments
NPI 1922472422 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $935 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $250 |
| Viatris Specialty LLC | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: NUCALA, YUPELRI, GLASSIA, Ohtuvayre, ZEPBOUND, BREZTRI.
Industry payments across WI — which companies pay providers there.
